The 11th International Congress of the European Association for Clinical Pharmacology and Therapeutics will be held at the International Congress Centre of Geneva from 28 to 31 August 2013.
Registration will open 10th October 2012. Abstract submissions will also open 10th November 2012 and will close 15th April 2013. To receive updates on the congress before registering, you can submit your email address to the congress organisers.
Over 900 participants are expected to attend including
health professionals, scientists, policy makers, biotechnology and
pharmaceutical professionals and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.
Aims of the Congress
To promote health and evidence-based
management of chronic illness in an ageing population
To showcase recent advances in translational medicine and therapeutics
To explore recent developments in the drug discovery pathway
To promote safe use of medicines
To promote effective
and safe utilisation of clinical pharmacological services in health care
delivery
To improve and harmonise the teaching of the rational use of drugs
To contribute
clinical pharmacological expertise to policy decisions in Europe and beyond
To promote high professional standards in drug prescribing
To promote high ethical standards in clinical drug research
Key
themes of the 2013 EACPT Geneva Congress
Assessment
of health therapies
Bedside
pharmacology for special patients
Clinical
trial methodologies
Clinical
trial regulation, controls and benefits
Collaborations
on vaccines
Diabetes
mellitus
Doping:
Sports and Pharmacologists
Drug
interactions
Drug
safety in emerging countries
Drug
Safety: from clinical trials to clinical practice
Ethics
Gene
therapy: expectations versus reality
Health
economic assessment
Health
issues and communication
How
to become a good prescriber
How
to become a good clinical pharmacologist
How
to become a self-empowered patient
Inflammatory
disease and biotherapeutics
Neuro-psychopharmacology:
filling the gaps
New
developments in therapeutic drug monitoring
New
paradigms in drug development
New
targets for pain treatment
Ocular
Pharmacology
Orphan
drugs
Pain
control devices
Pharmacology
and society
Pharmacology
of chocolate
Pharmacovigilance
(WHO)
PK/PD
modelling
Precision
/ Personalizing cancer therapy
Predictive
Pharmacogenetics
Special
cardiovascular pharmacology
Special
liver pharmacology
Special
populations (prenatal pharmacology)
The
use of molecular imaging biomarkers in drug development
Toxicentre
networks
Updates
in clinical toxicology
What's
new in malaria therapeutics
Who
should initiate drug development?
For
further information on the August 2013 Congress
Secretariat email: eacptreg@mci-group.com
No comments:
Post a Comment